Angioid Streaks: Clinical Trials

11 trials for Angioid Streaks, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 withdrawn, 1 recruiting, 1 terminated. 4 Phase 2, 2 Not applicable, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Withdrawn 2
Not applicable2Unknown 1, Withdrawn 1
Phase 12Completed 1, Withdrawn 1
Phase 32Completed 1, Terminated 1

Follow Angioid Streaks: new trials by email Literature Review of Angioid Streaks trials Research Report on Angioid Streaks

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Progression Assessment of PXE-associated Alterations
Pseudoxanthoma Elasticum, Angioid Streaks
RecruitingUniversity Hospital, Bonn1002024-09-012025-07-02
Antiangiogenic Therapy of CNV Associated With Angioid Streaks
Intravitreal injection - Angioid Streaks of Macula
Not applicableUnknownThe Filatov Institute of Eye Diseases and Tissue Therapy1002018-03-272021-02-03
Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients (ASTRID).
Aflibercept - Choroidal Neovascularization in Angioid Streaks
Phase 2WithdrawnHospices Civils de Lyon2016-02-012017-01-06
Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE)
Aflibercept - Pseudoxanthoma Elasticum
Phase 2CompletedUniversity Hospital, Bonn152015-09-012019-05-07
Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
Bevacizumab (Avastin; Genentech, Inc.), Bevacizumab, Dexamethasone, Verteporfin Photodynamic Therapy - Choroidal Neovascularization, Myopia
Not applicableWithdrawnMassachusetts Eye and Ear Infirmary2010-08-012014-01-14
Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid Streaks
ranibizumab - Angioid Streaks
Phase 1 / Phase 2WithdrawnUniversity of Illinois at Chicago2009-12-012012-07-02
Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)
Intravitreal injection ranibizumab - Choroidal Neovascularization
Phase 2CompletedUniversity Hospital, Bonn102007-08-012012-06-15
Intravitreal Bevacizumab in Agioid Streaks
intravitreal injection - Angioid Streaks, Choroidal Neovascularization
Phase 1CompletedUniversity of Campania Luigi Vanvitelli52006-11-012016-02-08
Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks
Intravitreal Bevacizumab - Angioid Streaks, Choroidal Neovascularization
Phase 3TerminatedAsociación para Evitar la Ceguera en México2005-11-012024-06-03
Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)
bevacizumab - Choroidal Neovascularization
Phase 3CompletedShahid Beheshti University of Medical Sciences312005-11-012008-07-11
Evolution of Visual Impairment During Pseudoxanthoma Elasticum
Pseudoxanthoma Elasticum
CompletedEuropean Georges Pompidou Hospital382000-01-012007-11-07

Narrower conditions

Choroidal Neovascularization (8)  ·  Pseudoxanthoma Elasticum (4)  ·  Central Serous Chorioretinopathy (1)  ·  Eye Diseases, Hereditary (1)  ·  Multifocal Choroiditis (1)  ·  Myopia (1)  ·  White Dot Syndromes (1)  ·  Wounds and Injuries (1)

Broader conditions

Eye Diseases (11)  ·  Retinal Diseases (11)  ·  Choroid Diseases (8)  ·  Metaplasia (8)  ·  Neovascularization, Pathologic (8)  ·  Pathologic Processes (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Uveal Diseases (8)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Genetic Diseases, Inborn (5)  ·  Cardiovascular Diseases (4)  ·  Congenital Abnormalities (4)  ·  Connective Tissue Diseases (4)  ·  Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)

Interventions

Bevacizumab (2)  ·  Intravitreal Injections (2)  ·  Ranibizumab (2)  ·  aflibercept (2)  ·  Dexamethasone (1)  ·  Refractometry (1)

Sponsors

University Hospital, Bonn (3)  ·  Asociación para Evitar la Ceguera en México (1)  ·  European Georges Pompidou Hospital (1)  ·  Hospices Civils de Lyon (1)  ·  Massachusetts Eye and Ear Infirmary (1)  ·  Shahid Beheshti University of Medical Sciences (1)  ·  The Filatov Institute of Eye Diseases and Tissue Therapy (1)  ·  University of Campania Luigi Vanvitelli (1)  ·  University of Illinois at Chicago (1)

Countries

Germany (3)  ·  France (1)  ·  Iran (1)  ·  Italy (1)  ·  Mexico (1)  ·  Ukraine (1)

Top investigators

Andrii MD Korol, PhD (1)  ·  Frank G. Holz, MD (1)  ·  Frank G. Holz, MD, DPhil (1)  ·  Griselda Alvarez-Rivera, MD (1)  ·  Hamid Ahmadieh, MD (1)  ·  Hendrik PN Scholl, MD, MA (1)  ·  Hugo Quiroz-Mercado, MD (1)  ·  Ivana K Kim, MD (1)  ·  Jans Fromow-Guerra, MD PhD (1)  ·  Jennifer I Lim, MD (1)  ·  Michele Rinaldi, MD (1)

Results publications

PMID 21704964, PMID 40522203

NIH funding

2014 (1)